Skip Navigation


Human Molecular Genetics Advance Access originally published online on March 10, 2006
Human Molecular Genetics 2006 15(8):1279-1289; doi:10.1093/hmg/ddl045
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
15/8/1279    most recent
ddl045v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Taniguchi, M.
Right arrow Articles by Toda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taniguchi, M.
Right arrow Articles by Toda, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in {alpha}-dystroglycanopathies

Mariko Taniguchi1, Hiroki Kurahashi3, Satoru Noguchi4, Takayasu Fukudome5, Takeshi Okinaga2, Toshifumi Tsukahara6, Youichi Tajima7, Keiichi Ozono2, Ichizo Nishino4, Ikuya Nonaka4 and Tatsushi Toda1,*

1Division of Clinical Genetics, Department of Medical Genetics and 2Department of Pediatrics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan, 3Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan, 4National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan, 5Division of Clinical Research, Nagasaki Medical Center of Neurology, Kawatanamachi, Nagasaki 859-3615, Japan, 6Center for Nano Materials and Technology, Japan Advanced Institute of Science and Technology, Tatsunokuchi, Ishikawa 923-1292, Japan and 7Department of Clinical Genetics, The Tokyo Metropolitan Institute of Medical Science, Bunkyo-ku, Tokyo 113-8613, Japan

* To whom correspondence should be addressed. Tel: +81 668793380; Fax: +81 668793389; Email: toda{at}clgene.med.osaka-u.ac.jp

Received October 15, 2005; Accepted February 28, 2006

Recent studies have revealed an association between post-translational modification of {alpha}-dystroglycan ({alpha}-DG) and certain congenital muscular dystrophies known as secondary {alpha}-dystroglycanopathies ({alpha}-DGpathies). Fukuyama-type congenital muscular dystrophy (FCMD) is classified as a secondary {alpha}-DGpathy because the responsible gene, fukutin, is a putative glycosyltransferase for {alpha}-DG. To investigate the pathophysiology of secondary {alpha}-DGpathies, we profiled gene expression in skeletal muscle from FCMD patients. cDNA microarray analysis and quantitative real-time polymerase chain reaction showed that expression of developmentally regulated genes, including myosin heavy chain (MYH) and myogenic transcription factors (MRF4, myogenin and MyoD), in FCMD muscle fibers is inconsistent with dystrophy and active muscle regeneration, instead more of implicating maturational arrest. FCMD skeletal muscle contained mainly immature type 2C fibers positive for immature-type MYH. These characteristics are distinct from Duchenne muscular dystrophy, suggesting that another mechanism in addition to dystrophy accounts for the FCMD skeletal muscle lesion. Immunohistochemical analysis revealed morphologically aberrant neuromuscular junctions (NMJs) lacking MRF4 co-localization. Hypoglycosylated {alpha}-DG indicated a lack of aggregation, and acetylcholine receptor (AChR) clustering was compromised in FCMD and the myodystrophy mouse, another model of secondary {alpha}-DGpathy. Electron microscopy showed aberrant NMJs and neural terminals, as well as myotubes with maturational defects. Functional analysis of NMJs of {alpha}-DGpathy showed decreased miniature endplate potential and higher sensitivities to d-Tubocurarine, suggesting aberrant or collapsed formation of NMJs. Because {alpha}-DG aggregation and subsequent clustering of AChR are crucial for NMJ formation, hypoglycosylation of {alpha}-DG results in aberrant NMJ formation and delayed muscle terminal maturation in secondary {alpha}-DGpathies. Although severe necrotic degeneration or wasting of skeletal muscle fibers is the main cause of congenital muscular dystrophies, maturational delay of muscle fibers also underlies the etiology of secondary {alpha}-DGpathies.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
M. Kanagawa, A. Nishimoto, T. Chiyonobu, S. Takeda, Y. Miyagoe-Suzuki, F. Wang, N. Fujikake, M. Taniguchi, Z. Lu, M. Tachikawa, et al.
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy
Hum. Mol. Genet., February 15, 2009; 18(4): 621 - 631.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.